Literature DB >> 35099669

Good 5-year postoperative outcomes after facet fusion using a percutaneous pedicle screw system for degenerative lumbar spondylolisthesis.

Tomohiro Miyashita1, Hiromi Ataka2, Kei Kato3, Takaaki Tanno2.   

Abstract

Many authors have reported no significant differences in clinical outcomes between posterolateral fusion (PLF) and interbody fusion, as well as satisfactory long-term outcomes after PLF. Facet fusion (FF), a minimally invasive evolution of PLF, has also resulted in good clinical outcomes. This study aimed to assess the clinical outcomes 5 years after FF for degenerative lumbar spondylolisthesis (DLS) and determine whether good clinical outcomes were maintained after FF. Records of 115 patients who underwent FF for single-level DLS with at least 5 years of follow-up were retrospectively studied. The therapeutic effectiveness of FF was assessed as a clinical outcome using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ), the Roland-Morris Disability Questionnaire (RMDQ), and the visual analogue scale (VAS) preoperatively and at 1 and 5 years postoperatively. Computed tomography was performed for fusion confirmation. The revision surgery rate was also evaluated. The JOABPEQ category scores demonstrated therapeutic effectiveness in 81.7% of patients at 1 year postoperatively and 81.4% of patients at 5 years postoperatively for low back pain; the corresponding proportions for walking ability were 93.8% and 86.6%, respectively. There were no significant differences in therapeutic effectiveness at 1 and 5 years postoperatively for any category, including the RMDQ and VAS scores. The fusion rate was 90.4% at the final follow-up. Four patients required revision surgery for adjacent segment disease 1-5 years after the first surgery (revision surgery rate, 3.5%). Good clinical outcomes were maintained 5 years after FF, and FF had an extremely low revision surgery rate.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adjacent segment disease; Facet joint fusion; Fusion rate; In situ fusion; Nonunion; Posterolateral fusion

Year:  2022        PMID: 35099669     DOI: 10.1007/s10143-022-01747-x

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  12 in total

1.  Posterolateral Versus Transforaminal Interbody L4/5 Fusion: Correlation With Subsequent Surgery.

Authors:  Christian J Gaffney; Manuel R Pinto; Abdul F Buyuk; Timothy A Garvey; Benjamin Mueller; James D Schwender; Ensor E Transfeldt; Harrison K Tam; John M Dawson
Journal:  Clin Spine Surg       Date:  2019-03       Impact factor: 1.876

2.  Minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis and degenerative spondylosis: 5-year results.

Authors:  Yung Park; Joong Won Ha; Yun Tae Lee; Na Young Sung
Journal:  Clin Orthop Relat Res       Date:  2013-08-18       Impact factor: 4.176

3.  Reoperation rate and risk factors of elective spinal surgery for degenerative spondylolisthesis: minimum 5-year follow-up.

Authors:  Shunsuke Sato; Mitsuru Yagi; Masayoshi Machida; Akimasa Yasuda; Tsunehiko Konomi; Atsushi Miyake; Kanehiro Fujiyoshi; Shinjiro Kaneko; Masakazu Takemitsu; Masafumi Machida; Yoshiyuki Yato; Takashi Asazuma
Journal:  Spine J       Date:  2015-02-11       Impact factor: 4.166

4.  Fusion technique does not affect short-term patient-reported outcomes for lumbar degenerative disease.

Authors:  Srikanth N Divi; Gregory D Schroeder; Dhruv K C Goyal; Kristen E Radcliff; Matthew S Galetta; Alan S Hilibrand; D Greg Anderson; Mark F Kurd; Jeffrey A Rihn; Ian D Kaye; Barrett R Woods; Alexander R Vaccaro; Christopher K Kepler
Journal:  Spine J       Date:  2019-07-26       Impact factor: 4.166

5.  Lumbar instrumented posterolateral fusion in spondylolisthetic and failed back patients: a long-term follow-up study spanning 11-13 years.

Authors:  Veli Turunen; Timo Nyyssönen; Hannu Miettinen; Olavi Airaksinen; Timo Aalto; Juhana Hakumäki; Heikki Kröger
Journal:  Eur Spine J       Date:  2012-04-24       Impact factor: 3.134

6.  Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.

Authors:  Scott L Parker; Owoicho Adogwa; Alexandra R Paul; William N Anderson; Oran Aaronson; Joseph S Cheng; Matthew J McGirt
Journal:  J Neurosurg Spine       Date:  2011-02-18

7.  Good clinical outcomes in nonunion cases after facet fusion with a percutaneous pedicle screw system for degenerative lumbar spondylolisthesis.

Authors:  Tomohiro Miyashita; Hiromi Ataka; Kei Kato; Hiromitsu Takaoka; Takaaki Tanno
Journal:  Neurosurg Rev       Date:  2021-01-20       Impact factor: 3.042

8.  Minimum clinically important difference of major patient-reported outcome measures in patients undergoing decompression surgery for lumbar spinal stenosis.

Authors:  Yoji Ogura; Koichi Ogura; Yoshiomi Kobayashi; Takahiro Kitagawa; Yoshiro Yonezawa; Yoshiyuki Takahashi; Kodai Yoshida; Akimasa Yasuda; Yoshio Shinozaki; Jun Ogawa
Journal:  Clin Neurol Neurosurg       Date:  2020-05-30       Impact factor: 1.876

9.  Perioperative Effects Associated With the Surgical Treatment of Degenerative Spondylolisthesis: Interbody Versus No Interbody.

Authors:  Matthew W Colman; Lon M Baronne; Darrel S Brodke; Ashley M Woodbury; Prokopis Annis; Brandon D Lawrence
Journal:  Clin Spine Surg       Date:  2019-03       Impact factor: 1.876

10.  Potential significance of facet joint fusion or posteromedial fusion observed on CT imaging following attempted posterolateral or posterior interbody fusion.

Authors:  David H Kim; Raymond W Hwang; Gyu-Ho Lee; Riya Joshi; Kevin C Baker; Paul Arnold; Rick Sasso; Daniel Park; Jeffrey Fischgrund
Journal:  Spine J       Date:  2019-10-28       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.